Zylox-Tonbridge Medical Technology Co Ltd Class H 02190
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- HKD 10.72
- Day Range
- HKD 10.88–11.36
- 52-Week Range
- HKD 7.20–14.66
- Bid/Ask
- HKD 11.00 / HKD 11.10
- Market Cap
- HKD 3.63 Bil
- Volume/Avg
- 144,000 / 226,284
Key Statistics
- Price/Earnings (Normalized)
- 240.44
- Price/Sales
- 6.03
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- 1.70%
Company Profile
Zylox-Tonbridge Medical Technology Co Ltd is principally engaged in providing solutions to patients and physicians with a product portfolio covering peripheral-vascular interventional devices and neurovascular interventional devices in China and other countries. The company's main products include Thrombite Clot Retriever Device (Thrombite CRD) and Ultrafree Drug Coated PTA Balloon Catheter (Ultrafree DCB).
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 765
- Website
- https://www.zyloxtb.com
Comparables
Valuation
|
Metric
|
02190
|
301033
|
603301
|
|---|---|---|---|
Price/Earnings (Normalized) | 240.44 | 63.92 | 22.09 |
Price/Book Value | 1.03 | 4.26 | 1.07 |
Price/Sales | 6.03 | 11.24 | 1.55 |
Price/Cash Flow | 49.44 | 26.30 | 8.58 |
Price/Earnings
02190
301033
603301
Financial Strength
|
Metric
|
02190
|
301033
|
603301
|
|---|---|---|---|
Quick Ratio | 8.62 | 3.51 | 1.77 |
Current Ratio | 9.67 | 3.96 | 2.46 |
Interest Coverage | −347.73 | 21.90 | 3.93 |
Quick Ratio
02190
301033
603301
Profitability
|
Metric
|
02190
|
301033
|
603301
|
|---|---|---|---|
Return on Assets (Normalized) | 0.21% | 4.98% | 1.57% |
Return on Equity (Normalized) | 0.24% | 6.07% | 2.23% |
Return on Invested Capital (Normalized) | −2.29% | 5.57% | 1.68% |
Return on Assets
02190
301033
603301
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Gqfzhnk | Pkrnfs | $182.4 Bil | |
SYK
| Stryker Corp | Vlpzktkmd | Mvlqx | $127.2 Bil | |
MDT
| Medtronic PLC | Mrvtlynqq | Cfsktd | $113.7 Bil | |
BSX
| Boston Scientific Corp | Ktmvrqzm | Lcfpbv | $109.6 Bil | |
EW
| Edwards Lifesciences Corp | Gjldwffnm | Sfkdj | $54.3 Bil | |
DXCM
| DexCom Inc | Wkchdmxp | Dqjl | $52.2 Bil | |
PHG
| Koninklijke Philips NV ADR | Kkvnjsjp | Bdvwjs | $25.9 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Klvgmvvnd | Yhjt | $24.9 Bil | |
ALGN
| Align Technology Inc | Ylmwxccy | Kqgdjc | $20.6 Bil | |
SNN
| Smith & Nephew PLC ADR | Vnhvtwrh | Zkvkx | $11.4 Bil |